Check out this interview with Amber Capone of VETS, on studying ibogaine and 5-MeO-DMT for traumatic brain injuries.
How Mushrooms Started Going Mainstream
In the 1950s, Gordon and Valentina Wasson encountered magic mushrooms. Then they wouldn’t stop talking about them.
Read moreLooking at Psychedelics and Legalization
Michael Pollan looks at the legalization of some psychedelics and asks how should we do drugs now?
Read moreCan a Bad Trip Be a Good Thing?
Psychedelic users say that even bad trips gave them ‘life-altering insights’, a small study finds.
Read morePsychedelics As Medicine
Psychedelics are promising treatments for mental illness. Dozens of new startups have sprung up to develop and deliver the drugs to patients in need.
Read moreResearch of Psychedelics
How Magic Mushrooms Evolved
Why does nature produce hallucinogenic compounds? One study set out to uncover the answer... keep reading to find out more.
Read more50 Years of Psychedelic Progress
Check out this Q&A with Beckley Psytech Director & Chair of Scientific Advisory Board, Lady Amanda Feilding.
Amanda Feilding has been called the ‘hidden hand’ behind the renaissance of psychedelic science. Her contribution to global drug policy reform and to opening the doors to scientific research has been pivotal and widely acknowledged.
Read morePsilocybin and Terminally Ill Patients
This new study suggests that psilocybin may reduce suicidal thoughts in terminally ill patients.
Read moreInterview: Psilocybin for Depression
In this interview, leading psychedelic researcher, Robin Carhart-Harris, speaks with a participant in a psilocybin for depression trial on the potential of psychedelics.
Read moreLegalization vs. Decriminalization
Here’s some helpful information for understanding legalization v. decriminalization with psychedelics.
Read more